Multiple downstream receptors for paracrine factors

The term Multiple downstream receptors for paracrine factors refers to a functional grouping of cell-surface proteins that mediate signals from locally acting molecules, such as growth factors and cytokines, released by neighboring cells (paracrine signaling). These receptors primarily include members of the receptor tyrosine kinase (RTK) family, such as Vascular Endothelial Growth Factor Receptors (VEGFR), Fibroblast Growth Factor Receptors (FGFR), and Platelet-Derived Growth Factor Receptors (PDGFR) (Gschwind et al., 2004). In a physiological context, these receptors regulate essential processes like angiogenesis, wound healing, and tissue homeostasis; however, their dysregulation is a hallmark of malignancy and fibrotic disorders (Wollin et al., 2015). In cancer, paracrine loops between tumor cells and the stroma promote tumor growth, metastasis, and resistance to therapy. Therapeutic intervention often involves the use of multi-kinase inhibitors, such as nintedanib or lenvatinib, which simultaneously block several of these receptors to achieve a more comprehensive inhibition of complex signaling networks (Hilberg et al., 2008). Because this entry describes a broad category of distinct molecular entities rather than a single specific protein or complex, it is not considered a canonical therapeutic target name in pharmacological databases.

Other names

Paracrine signaling receptorsDownstream paracrine effectorsMulti-kinase targets

Inhibition of multiple receptor tyrosine kinases (RTKs) that are activated by paracrine growth factors, thereby disrupting local signaling loops that drive disease progression.